Get started
Scilex Holding CompanyScilex Holding CompanyScilex Holding Company

Scilex Holding Company

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

SCLX chart


Full chart

SCLX upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪109.24 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.0188 USD
Net income (FY)
‪−114.33 M‬ USD
Revenue (FY)
‪46.74 M‬ USD
Shares float
‪146.34 M‬
Beta (1Y)
2.25

Employees


Employees (FY)
105
Change (1Y)
+15 +16.67%
Revenue / Employee (1Y)
‪445.17 K‬ USD
Net income / Employee (1Y)
‪−1.09 M‬ USD

About Scilex Holding Company


Sector
Health Technology
CEO
Jaisim Shah
Headquarters
Palo Alto
Website
scilexholding.com
Founded
2020
FIGI
BBG00YJTT4L8
Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTlido, a prescription lidocaine topical product approved by the FDA for the relief of neuropathic pain associated with PHN, which is a form of post-shingles nerve pain, and e GLOPERBA oral solutions, an FDA-approved prophylactic treatment for painful gout flares in adults. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

SCLX news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of SCLX is 0.4197 USD — it has increased by 2.08% in the past 24 hours. Watch Scilex Holding Company stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Scilex Holding Company stocks are traded under the ticker SCLX.
SCLX stock has fallen by −10.43% compared to the previous week, the month change is a −16.06% fall, over the last year Scilex Holding Company has showed a −68.68% decrease.
We've gathered analysts' opinions on Scilex Holding Company future price: according to them, SCLX price has a max estimate of 14.00 USD and a min estimate of 6.25 USD. Watch SCLX chart and read a more detailed Scilex Holding Company stock forecast: see what analysts think of Scilex Holding Company and suggest that you do with its stocks.
SCLX reached its all-time high on Apr 5, 2023 with the price of 16.9000 USD, and its all-time low was 0.4300 USD and was reached on Dec 20, 2024. View more price dynamics on SCLX chart.
See other stocks reaching their highest and lowest prices.
SCLX stock is 22.39% volatile and has beta coefficient of 2.25. Track Scilex Holding Company stock price on the chart and check out the list of the most volatile stocks — is Scilex Holding Company there?
Today Scilex Holding Company has the market capitalization of ‪109.24 M‬, it has decreased by −2.74% over the last week.
Yes, you can track Scilex Holding Company financials in yearly and quarterly reports right on TradingView.
Scilex Holding Company is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
SCLX earnings for the last quarter are −0.10 USD per share, whereas the estimation was −0.09 USD resulting in a −11.11% surprise. The estimated earnings for the next quarter are −0.13 USD per share. See more details about Scilex Holding Company earnings.
Scilex Holding Company revenue for the last quarter amounts to ‪18.45 M‬ USD, despite the estimated figure of ‪17.87 M‬ USD. In the next quarter, revenue is expected to reach ‪20.58 M‬ USD.
SCLX net income for the last quarter is ‪−37.58 M‬ USD, while the quarter before that showed ‪−24.38 M‬ USD of net income which accounts for −54.17% change. Track more Scilex Holding Company financial stats to get the full picture.
No, SCLX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 105.00 employees. See our rating of the largest employees — is Scilex Holding Company on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Scilex Holding Company EBITDA is ‪−94.85 M‬ USD, and current EBITDA margin is −216.68%. See more stats in Scilex Holding Company financial statements.
Like other stocks, SCLX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Scilex Holding Company stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Scilex Holding Company technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Scilex Holding Company stock shows the sell signal. See more of Scilex Holding Company technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.